ClinicalTrials.Veeva

Menu

A Study of the Metabolic Syndrome in Patients With Systemic Lupus Erythematosus

F

Far Eastern Memorial Hospital

Status

Completed

Conditions

Cardiovascular Risk Factors
Systemic Lupus Erythematosus
Metabolic Syndrome

Study type

Observational

Funder types

Other

Identifiers

NCT00982670
FEMH-96-D-032

Details and patient eligibility

About

An increased prevalence of the metabolic syndrome has been found in patients with systemic lupus erythematosus in recent years.

Full description

This study will investigate the prevalence of the metabolic syndrome in patients with SLE in Taiwan. We expect our study will provide further understanding of the association between SLE and metabolic syndrome, which may give direction to prevent late cardiovascular morbidity and mortality in SLE patients.

Enrollment

100 patients

Sex

All

Ages

18 to 80 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Persons aged 18 and above.
  • Persons fulfill the diagnostic criteria of the 1997 American College of Rheumatology for systemic lupus erythematosus in the patient group.

Exclusion criteria

  • Exclude a history myocardial infarction, angina or stroke.

Trial design

100 participants in 2 patient groups

Systemic lupus erythematosus
Description:
Patients should fulfill the diagnostic criteria of the 1997 American College of Rheumatology for systemic lupus erythematosus
Normal control
Description:
Age- and sex-matched health volunteers will serve as controls.

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems